Trial Profile
Open-Label Study to Investigate the Humoral and Cellular Immune Response to Two Doses of VAX102 Influenza Vaccine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2014
Price :
$35
*